Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q4 2025 Earnings Call Transcript

Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q4 2025 Earnings Call Transcript March 26, 2026

Insight Molecular Diagnostics Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.2375.

Gabrielle Woody: Welcome, everyone, and thank you for joining us to discuss Insight Molecular Diagnostics Fourth Quarter 2025 Results. If you have not seen today’s shareholder letter, please visit Insight Molecular Diagnostics Investor Relations page at...